Maruti Suzuki Q2 PAT seen up 2X at Rs 597 cr

Published on Fri, Oct 23, 2009 at 18:48 |  Source : CNBC-TV18

Updated at Sat, Oct 24, 2009 at 12:13  

47495 Investors following Maruti Suzuki. Share this News with them.
0
0
Share on Tumblr
Maruti Suzuki Q2 PAT seen up 2X at Rs 597 cr

ALSO READ

Maruti Suzuki India is to announce its second quarter results. According to CNBC-TV18 estimates, the company's Q2FY10 revenues are seen up 47% at Rs 7091 crore versus Rs 4830 crore.

 

Its OPM at 13.3% versus 7%.

 

The company's PAT up 2X at Rs 597 crore versus Rs 296 crore.

 

Factors to watch out for:

 

In Q2FY10, Expect robust volume bump up of 30% in Q2FY10 result in higher sales due to improved consumer sentiment

Launch of Ritz and exports of A-Star augured well for Maruti

Realization is expected to rise 10.7% YoY (up 0.5% QoQ), reflecting an improved product mix towards A3 and higher export realizations (due to fresh hedges at higher rates

May surprise positively, as the impact of JPY appreciation could beoffset by an appreciating EUR

Low promotion spends and additional steel price benefit should aid sequential margin expansion.

Key thing to look for in the results is be management guidance on steel pricing contract, which the company would enter into in Q3FY10.

Higher depreciation will restrict recurring PAT growth to 111% or Rs6.26b.

Demand recovery in urban markets

 

Volumes Growth YoY

Total sales up 30%

Domestic sales up 22%  

Exports up more than 2X to 37105 units, led by A Star demand in Europe

  

Trending News

Business News

Tim Cook speaks candidly about Apple at D10
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

Ashwini Kumar Says On CNBC-TV18 Expect India Growth Story To March Forward

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!